CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology
Kill Switch for CRISPR Could Make Gene Editing Safer - Scientific American
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
CRISPR gene editing - Wikipedia
First CRISPR editing trial results assuage safety concerns
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
A CRISPR Approach to Treating Sickle Cell – NIH Director's Blog
New CRISPR genome-editing system can target disease-causing genetic variations – Harvard Gazette
Untangling the CRISPR cancer scare
Is Crispr the Next Antibiotic? - The New York Times
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
Precision CRISPR system averts hearing loss in mice - Boston Children's Discoveries
Four U.S. CRISPR Trials Editing Human DNA to Research New Treatments | Science | Smithsonian Magazine
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development
CRISPR, the disruptor : Nature News & Comment
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL
A new research revealed that the CRISPR–Cas9 genome editing technique may increase cancer risk - Biotech Advisers
Developing CRISPR/CAS9 technologies for research and medicine - MedCrave online
First Trial of CRISPR-Edited T cells in Lung Cancer: Trends in Molecular Medicine
